The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing kidney failure risk, disease progression, and death due to ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

FAT loss jabs have been spotted being flogged for £40 on TikTok as hundreds of Brits have been hospitalised with “serious ...

A special investigation by the Manchester Evening New's Nicole Wootton-Cane has revealed the Ozempic and Wegovy sold on the ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

There are around 80 patients who are currently prescribed weight-loss jab Wegovy solely for obesity treatment and the GHA is looking to review guidance for the new highly-effective drug Mounjaro with ...

Many of them have only been approved for sale in the last few years. The most widely known of GLP-1 drugs, semaglutide is sold under well-known brand names such as Ozempic and Wegovy. According to the ...

That’s largely because the country is home to Novo Nordisk, the maker of Ozempic and Wegovy, the popular weight-loss drugs. The company is so important to the Danish economy — it has recently ...

vaccines as he says he's ready to take role with Trump administration Fluoride in drinking water might be less beneficial today Researchers found a 1.14-point decrease in IQ score for every 1 mg/L ...